Literature DB >> 518075

Assay of serum tobramycin levels with the Bactec 460.

L E Phillips, R R Martin, L O Gentry, T E Rogers.   

Abstract

Serum tobramycin levels of synthetic and patient specimens were determined by the Bactec 460. The results were compared with those obtained from the same specimens by radioimmunoassay. These studies suggest that assays performed by either method should be run in duplicate or triplicate to achieve maximum accuracy. The studies also suggest that results obtained by the Bactec method are at least as reliable as those obtained by the radioimmunoassay method.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518075      PMCID: PMC352883          DOI: 10.1128/AAC.16.4.463

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Gentamicin blood levels: a guide to nephrotoxicity.

Authors:  J G Dahlgren; E T Anderson; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

2.  Radioimmunoassay of iodinated tobramycin.

Authors:  A Broughton; J E Strong; L K Pickering; G P Bodney
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

3.  Serum levels of gentamicin and tobramycin after slow intravenous bolus injection.

Authors:  B C Stratford; S Dixson; A J Cobcroft
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

4.  Tobramycin ototoxicity.

Authors:  T B Logan; J Prazma; W G Thomas; N D Fischer
Journal:  Arch Otolaryngol       Date:  1974-03

5.  [Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].

Authors:  H Lode; B Kemmerich; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

6.  A comparative study of the ototoxicity of tobramycin and gentamicin.

Authors:  R E Brummett; D Himes; B Saine; J Vernon
Journal:  Arch Otolaryngol       Date:  1972-12

7.  Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis.

Authors:  P Noone; T M Parsons; J R Pattison; R C Slack; D Garfield-Davies; K Hughes
Journal:  Br Med J       Date:  1974-03-16

8.  Aminoglycoside antibiotics. VII. Acute toxicity of aminoglycoside antibiotics.

Authors:  K Fujisawa; T Hoshiya; H Kawaguchi
Journal:  J Antibiot (Tokyo)       Date:  1974-09       Impact factor: 2.649

  8 in total
  3 in total

1.  Comparison of the latex agglutination inhibition assay for tobramycin with radioimmunoassay.

Authors:  S D Sears; H C Standiford; D Bernstein; H C Nipper; B A Tatem; U Smalls; E Caplan
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

2.  Comparison of radioimmunoassay with a new immunofluorescent method (FIAX) for measuring tobramycin in serum.

Authors:  D A Bruckner; J A Hindler; W J Martin; R Palmer
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

3.  Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin.

Authors:  L E Phillips; R F Martin; W E Luper; T E Rogers
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.